Skip to main content

Mercedes Arrue Gonzalo

I graduated in biology with a specialty in neurobiology in Madrid. After completing a master's degree in pharmacological research, I completed my PhD investigating the influence of diesel exhaust particles on ischemic stroke in the group of neurovascular diseases. Where I currently continue to develop my work.

Institutions of which they are part

Postdoctoral researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Mercedes Arrue Gonzalo

Institutions of which they are part

Postdoctoral researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

I graduated in biology with a specialty in neurobiology in Madrid. After completing a master's degree in pharmacological research, I completed my PhD investigating the influence of diesel exhaust particles on ischemic stroke in the group of neurovascular diseases. Where I currently continue to develop my work.

PhD in Neuroscience (2018-2022)
Master in Pharmacological research (2017-2018)
Degree in Biology (2007-2013)

Projects

Influence of Diesel Exhaust Particles as a Major Air Pollutant in Brain Injury and Repair after Experimental Stroke.

IP: Anna Rosell Novel
Collaborators: Mercedes Arrúe Gonzalo, Mª Jesús Cruz Carmona, Guillem Colell Dinares
Funding agency: Fundació La Marató de TV3
Funding: 200000
Reference: 20173110
Duration: 01/01/2018 - 30/09/2021

Incorporació Dr. Joan Montaner a la RETICS en Malalties vasculars cerebrals (ICTUS)

IP: -
Collaborators: Anna Rosell Novel, Mercedes Arrúe Gonzalo, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez, Guillem Colell Dinares, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel
Funding agency: Instituto de Salud Carlos III
Funding: 240669
Reference: RD16/0019/0021
Duration: 01/01/2017 - 31/12/2021

Related news

The initiative seeks to raise awareness of the disease and promote the well-being of those affected, while fostering empathy and scientific vocations among young people.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

Related professionals

González Sánchez Alejandra

González Sánchez Alejandra

Predoctoral researcher
Microbiology
Read more
Rodrigo Maluje Juri

Rodrigo Maluje Juri

Predoctoral researcher
Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Marta Antonio Martín

Marta Antonio Martín

Predoctoral researcher
Cardiovascular Diseases
Read more
Marina Llanas Martinez

Marina Llanas Martinez

Predoctoral researcher
Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.